ENVB

Enveric Biosciences, Inc.

Healthcare · Biotechnology

$258.04 sample

-4.00 (-1.53%) 1D

Market cap

$1.48T

Price as of

2026-10-15

Latest filing

8-K · 2026-08-31

Alerts

8

Price$258.04 -1.83% 3M daily closessample

268.08253.87

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: Chief Executive Officer
Oct 08INSInsider sell: EVP, Operations
Sep 30INSInsider sell: Chief Executive Officer
Sep 23INSInsider buy: Chief Financial Officer
Sep 18INSInsider buy: Chief Executive Officer
Sep 14INSInsider sell: Chief Executive Officer
Sep 08INSInsider sell: General Counsel
Aug 31SEC10-Q filed

Sign up to see the real ENVB record →

Company facts

SEC EDGAR registration

Name: Enveric Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -28sample, -100 to +100
Reporting currency: USD

Who is positioning in ENVB

sample

Insiders: 21 insider transactions over 90 days, net selling, $91.9M
Congress: 3 members traded over 90 days
Institutions · 13F: 22 funds hold $18.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$67.9B +20.0% y/y

Q4 2024Q3 2026

Inventory$40.1B +16.1% y/y

Q4 2024Q3 2026

Accounts receivable$31.2B +17.0% y/y

Q4 2024Q3 2026

Total debt$78.7B +13.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $922.4B +8.0% 3M
Sample peer B: $1.14T +15.2% 3M
Sample peer C: $543.9B +0.4% 3M
Sample peer D: $201.2B +13.7% 3M
Sample peer E: $1.15T +16.4% 3M